STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Neumora Therapeutics, Inc.

Filed

October 29, 2025

Period of Report

October 27, 2025

Accession Number

0001012975-25-000680